Galapagos NV (NASDAQ:GLPG)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $51.90, but opened at $52.47. Galapagos NV shares last traded at $54.57, with a volume of 25,543 shares trading hands.

A number of equities analysts recently commented on GLPG shares. Zacks Investment Research downgraded Galapagos NV from a “buy” rating to a “hold” rating in a report on Monday, July 4th. Credit Suisse Group AG restated a “hold” rating and set a $48.00 target price on shares of Galapagos NV in a report on Friday, June 17th. Morgan Stanley decreased their target price on Galapagos NV from $92.00 to $89.00 and set an “overweight” rating for the company in a report on Monday, May 2nd. Finally, Cowen and Company restated a “buy” rating on shares of Galapagos NV in a report on Saturday, April 30th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of €65.50 ($72.78).

The stock has a 50-day moving average price of $53.62 and a 200-day moving average price of $48.86. The stock’s market capitalization is $2.54 billion.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.